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Kisspeptins are a family of overlapping neuropeptides encoded by the Kiss1 gene that
regulate the mammalian reproductive axis by a central action in the hypothalamus to stim-
ulate GnRH release. Kisspeptins and their receptor (GPR54 also called KISS1R) are also
expressed in the testes but a functional role in this tissue has not been confirmed. We
examined which cell types in the testes expressed kisspeptin and its receptor by stain-
ing for β-galactosidase activity using tissue from transgenic mice with LacZ targeted to
either the Kiss1 or the Gpr54 genes. Expression of both genes appeared to be restricted
to haploid spermatids and this was confirmed by a temporal expression analysis, which
showed expression appearing with the first wave of haploid spermatid cells at puberty.
We could not detect any kisspeptin protein in spermatids however, suggesting that the
Kiss1 mRNA may be translationally repressed. We tested whether kisspeptin could act on
Leydig cells by examining the effects of kisspeptin on the immortalized Leydig cell line MA-
10. Although MA-10 cells were shown to express Gpr54 by RT-PCR, they did not respond
to kisspeptin stimulation. We also tested whether kisspeptin could stimulate testosterone
release by a direct action on the testes using explants of seminiferous tubules.The explants
did not show any response to kisspeptin. The functional integrity of the MA-10 cells and
the seminiferous tubule explants was confirmed by showing appropriate responses to the
LH analog, human chorionic gonadotropin. These data suggest that kisspeptin signaling
does not have a significant role in testes function in the mouse.
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INTRODUCTION
Kisspeptins, encoded by the Kiss1 gene, are an overlapping fam-
ily of neuropeptides required for activation and maintenance
of the mammalian reproductive axis [for review, see Ref. (1)].
Kisspeptins are encoded as a 145-amino-acid precursor protein in
humans that is cleaved into shorter peptides (Kp54, Kp14, Kp13,
and Kp10) that share a common RF-amide C-terminal decapep-
tide sequence. They all act as potent stimulators of GnRH release
by signaling through the G-protein coupled receptor, GPR54
(also called KISS1R) expressed by GnRH neurons. Disruption of
kisspeptin signaling causes hypogonadotropic hypogonadism in
mice and humans (2–7). Mutant mice do not undergo sexual mat-
uration at puberty and have low gonadotropic and sex steroid
hormones levels caused by defective GnRH secretion from the
hypothalamus. Conversely, activating mutations of GPR54 cause
precocious puberty in humans (8).
In addition to the role of kisspeptins in the central regula-
tion of the reproductive axis, Gpr54 expression has been detected
in the testes of humans (9, 10), mice (3), rats (11), and frogs
(12) raising the possibility that kisspeptins may also act at this
location. Kisspeptins have been immunolocalized to Leydig cells
in mice (13) and kisspeptin and GPR54 have been detected in
human sperm,mainly localized to the head,neck,and the flagellum
midpiece (14).
Although the expression profile of Kiss1 and Gpr54 suggests
that kisspeptin signaling might have a role in the testes, very little
has been done to test this hypothesis. The data to support a role
for kisspeptin in the testes is largely circumstantial and based on
discrepancies between the normally direct relationship of LH and
testosterone levels. For example, in rats, chronic (13 days) subcu-
taneous administration of kisspeptin reduced testosterone secre-
tion without a significant decrease in plasma LH (15). In Rhesus
monkeys, continuous intravenous infusion of human kisspeptin
over 4 days maintained plasma testosterone levels even after the
LH stimulation levels had fallen (16). When circulating testos-
terone levels were expressed relative to LH levels, the [T]:[LH]
ratios were significantly higher in the morning in the high dose
kisspeptin treatment group compared to the vehicle group. This
led to the suggestion that kisspeptins might augment the LH-
induced secretion of testosterone. Support for this has come from
kisspeptin administration in Rhesus monkeys pre-treated with
acyline, a GnRH receptor antagonist, to allow the intratesticu-
lar actions of kisspeptin to be evaluated without the confounding
effects of LH release from the pituitary (17). Kisspeptin admin-
istration significantly increased human chorionic gonadotropin
(hCG)-stimulated testosterone levels in acycline treated monkeys
compared to hCG treatment alone (17) suggesting that kisspeptin
might enhance LH responses in Leydig cells.
To further investigate the possible function(s) of kisspeptin in
the mouse testes, we used transgenic mice with Kiss1 and Gpr54
alleles targeted with a LacZ reporter gene to define the testicu-
lar cell expression profile of these genes. We also tested whether
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kisspeptins can stimulate testosterone release from an immortal-
ized mouse Leydig cell line and from primary testes explants in
culture.
MATERIALS AND METHODS
MOUSE LINES AND MAINTENANCE
The 129S6/SvEv mutant mice with a targeted disruption of the
Gpr54 or Kiss1 genes were generated as described previously (2,
5). All mice were maintained on a 12:12-h light-dark cycle (light
on between 6:30 a.m. and 6:30 p.m.) with ad libitum access to
food and water. Experimental procedures were performed under
authority of a Home Office Project License and approved by a
Local Ethics Committee.
MA-10 CELL CULTURE
The mouse Leydig tumor cell line MA-10 (18) was a gener-
ous gift from Dr. Mario Ascoli (University of Iowa, Iowa City,
IA, USA). The MA-10 cells were maintained in RPMI-1640
medium (Sigma-Aldrich, Dorset, UK) containing 10% horse
serum (Sigma-Aldrich, Dorset, UK) and 10% newborn calf serum
(Sigma-Aldrich, Dorset, UK), and the cells were grown at 37°C
in an humidified atmosphere of 5% CO2. The growth medium
was refreshed every 2 days to provide sufficient nutrition for cell
growth.
RT-PCR GENE EXPRESSION ANALYSIS OF MA-10 CELLS
Total RNA was isolated from MA-10 cells using a NucleoSpin®
RNA II kit (Cat No: 740955, MACHEREY-NAGEL GmbH &
Co. KG) following the manufacturer’s protocol. The time of the
on-column DNA digestion was extended from 15 to 45 min to
ensure complete removal of genomic DNA. The RNA was reverse
transcribed into cDNA using SuperScript III Reverse Transcrip-
tase (Cat No: 18080-044, Invitrogen, UK) following the protocol
provided by the manufacturer. Standard PCR was performed as
follows: the samples were denatured for 5 min at 95°C and ampli-
fied for 44 cycles (30 s at 93°C, 1 min at 60°C, and 2 min at
70°C). The primer sequences were: Kiss1 (Forward: tgctgcttctc-
ctctgtgtcg; Reverse: gccgaaggagttccagttgta, 310 bp product), Gpr54
(Forward: gccttcgcgctctacaacctgctg; Reverse: aaggcatagagcagcg-
gattgagc, 367 bp product),GnRH (Forward: cggcattctactgctgactgt;
Reverse: catcttcttctgcctggcttc, 229 bp product), β-actin (Forward:
ctgtattcccctccatcgtg; Reverse: gggtcaggatacctctcttgc, 113 bp prod-
uct). RNA without a reverse transcription step was used as a
negative control for identification of genomic DNA contamination
and cDNA from wild-type hypothalamus was used as a positive
control for Kiss1 amplification.
X-GAL STAINING OF TESTES SECTIONS
Testes were fixed in 1% paraformaldehyde/PBS overnight at
4°C, cryoprotected with 30% sucrose/PBS overnight at 4°C, and
cryosectioned at 20µm onto poly-lysine coated slides. Sections
were air dried at room temperature, rehydrated in PBS and β-
galactosidase activity detected using a LacZ staining solution
[1 mM MgCl2, 1 mg/ml X-gal (5-bromo-4-chloro-3-indolyl β-d-
galactopyranoside), 5 mM potassium ferricyanide, 5 mM potas-
sium ferrocyanide in PBS] at 37°C overnight, and counterstained
with 1% Saffronin.
IMMUNOHISTOCHEMISTRY TO DETECT KISSPEPTIN EXPRESSION
Testes were fixed in 4% paraformaldehyde/Tris-buffered saline
(TBS) for 5 h at room temperature and transferred to 30%
sucrose/TBS overnight at 4°C. The testes were then cryosectioned
at 15µM, air dried at room temperature, rehydrated in TBS, and
slide-mounted immunohistochemistry was performed to detect
kisspeptin expression. Polyclonal antibody AC566 raised in rab-
bits against mouse Kp10 was a generous gift from Alain Caraty,
Tours, France. Characterization and specificity of AC566 has been
described previously (5, 19–21).
Sections were treated with 3% hydrogen peroxide for 15 min to
quench endogenous peroxidase and then washed in TBS. To visu-
alize kisspeptin expression, sections were incubated with the anti-
body at 1:2000 dilution for 8 h at room temperature. For secondary
antibody labeling, sections were incubated with biotinylated goat
anti-rabbit (1:100; Cat No: BA-1000, Vector Laboratories, Peter-
borough, UK) immunoglobulins at room temperature followed
by incubation with Vector avidin-peroxidase (1:50; Cat No: PK-
4000,Vector Laboratories, Peterborough, UK). Finally, the sections
were rinsed and immunoreactivity was revealed with glucose-
oxidase and nickel-enhanced diaminobenzidine hydrochloride
(12.5 mg/ml). Sections were counterstain with hematoxylin, dehy-
drated in ethanol followed by Histoclear, and then coverslipped
with DPX.
PROGESTERONE RELEASE EXPERIMENTS FROMMA-10 CELLS
The MA-10 cells were seeded at 2.5× 105 cells/well (24-well plates)
24 h before the hormone treatment. The cells were treated with
increasing concentrations of Kp10 (human Metastin 45–54) (1,
10, or 20µM) (Cat No: M2816, Sigma-Aldrich, Dorset, UK) or
Kp10 followed by hCG (0.012 IU/ml as the final concentration)
(Cat No: CG5, Sigma, Saint Louis, MO, USA). PBS was added as
a negative control. Each condition was tested in triplicate. After
4 h, the media was collected for progesterone measurement. After
collection of media, the MA-10 cells were rinsed twice with PBS
and lysed in 1× lysis buffer (reporter lysis buffer, Cat No: E397A,
Promega, UK) by a freeze-thaw cycle. The lysate was briefly cen-
trifuged and the protein content of the supernatant determined
with a Bio-Rad Bradford Assay following the standard protocol.
PRIMARY CULTURE OF TESTES EXPLANTS
The testes from adult wild-type mice were cut into two pieces
(approximately 40 mg/piece) without removing the tunica and
each piece was cut and flattened to a 1-mm thickness on a Nylon
membrane (Cat No: 1417240, Boehringer-Mannheim, Indianapo-
lis, IN, USA) floating in phenol red-free DMEM medium (Cat No:
21063, GIBCO) (300µl/well for 12-well plate) supplemented with
1× penicillin/streptomycin. The tissues were immediately treated
with vehicle, Kp10 (1µM), hCG (0.6 IU/ml), or a mixture of Kp10
(1µM) and hCG (0.6 IU/ml), respectively. Each condition was
tested in at least four repeat wells. The tissues were cultured at
37°C in an atmosphere of 5% CO2 and the media collected at dif-
ferent time points. Fresh media was added at each time point after
media collection.
HORMONE ASSAYS
Testosterone and progesterone were measured using ELISA kits
(Cat No: EIA1559 and EIA1561 from DRG International, USA)
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according to the manufacturer’s instructions. The testosterone
ELISA kit had a sensitivity of 0.083 ng/ml, an inter-assay variation
of 6.7%, and an intra-assay variation of 3.3%. The progesterone
ELISA kit had a sensitivity of 0.045 ng/ml, intra-assay variation of
7%, and inter-assay variation of 5%.
RESULTS
Gpr54 AND KISS1 ARE EXPRESSED IN THE MOUSE TESTES
The Gpr54 and Kiss1 alleles in the transgenic mice have been
tagged with a LacZ gene that allows their gene expression patterns
to be visualized by staining for β-galactosidase activity. Staining
was observed within seminiferous tubules from both Kiss1+/−
(Figure 1A) and Gpr54+/−mice (data not shown) but not in wild-
type mice (Figure 1A). Background staining was observed in the
epididymis and the vas deferens of wild-type mice as the epithe-
lial cells in these tissues express an endogenous galactosidase-like
enzymatic activity. To define the cells in which Kiss1 and Gpr54 are
expressed, cryosection of testes were stained for β-galactosidase
activity. The staining in cryosections was localized to the region
of the seminiferous tubules that contained round spermatids
(arrowed in Figures 1B,C). The spermatids are easily recognized
as they have smaller nuclei than spermatocytes and are four-times
more abundant as they have just completed meiosis. Very faint
β-galactosidase staining was also found in the Leydig cells in the
Gpr54+/− mice (Figure 1D) but not in the Kiss1+/− mice (data
not shown).
To confirm that the β-galactosidase expression was localized
to spermatid cells, the time point at which expression was first
observed during the first spermatogenic cycle was determined.
Expression of Kiss1 and Gpr54 could not be observed prior to
3 weeks of age but staining was seen from 1 month of age which
corresponds to the time at which the spermatids first appear in
mice (Figure 2).
Kisspeptin protein expression in the mouse testes was visual-
ized using a well characterized rabbit antiserum highly specific for
mouse Kp10 (20). Strong immunoreactivity was found in Leydig
cells with no staining in spermatids (Figure 1E). As a control for
antibody specificity, testes sections from Kiss1 mutant mice lack-
ing kisspeptin protein were used and no immunoreactivity was
observed (Figure 1E). This Leydig staining may be non-specific
however, as no kisspeptin protein was detected in Gpr54 mutant
mice (data not shown).
Kp10 DOES NOT STIMULATE STEROIDOGENESIS IN THE LEYDIG CELL
LINE, MA-10
To test whether Kp10 could stimulate testosterone release, the
mouse Leydig cell line, MA-10, was used (18, 22). MA-10 cells,
like normal Leydig cells, express LH receptors and respond to
hCG stimulation. MA-10 cells have low expression and activity
of P450c17 that is the enzyme that converts progesterone into 17-
OH progesterone and finally into testosterone, thus MA-10 cells
produce progesterone as the principle steroid hormone instead of
testosterone (18, 22).
The MA-10 cells were examined for expression of Kiss1 and
Gpr54 to determine whether they might be capable of responding
to kisspeptins. There was a PCR product for Gpr54 (Figure 3A),
indicating that MA-10 cells endogenously express this gene but
FIGURE 1 | Kiss1 and Gpr54 expression in the mouse testes.
(A) Expression of Kiss1 in seminiferous tubules of the testes visualized by
X-gal staining (blue) for β-galactosidase activity. Note the non-specific
staining in the epididymis and vas deferens of the wild-type testes. Scale
bar= 5 mm. (B) Cryosections of testes from adult wild-type, Gpr54+/−, and
Kiss1+/− mice showing expression (arrowed) localized to spermatid cells of
seminiferous tubules. Sections were stained for β-galactosidase activity
(blue) and counterstained with Saffronin (red). Scale bar= 100µm.
(C)Testes cryosection from Kiss1+/− mice stained for β-galactosidase
activity (black dots, arrowed) and counterstained with DAPI to visualize cell
nuclei illustrating clearer expression in spermatid cells. Scale bar=100µm.
(D) Low expression of Gpr54 in Leydig cells visualized by X-gal staining.
Scale bar=50µm. (E) Kisspeptin immunoreactivity localized to Leydig cell
in wild-type mice (arrowed) but not Kiss1 mutant mice. Scale bar=200µm.
there was no detectable Kiss1 expression in the MA-10 cells.
The MA-10 cell also expressed GnRH and β-actin transcripts
(Figure 3A). No products were observed when non-transcribed
RNA was used as the template, indicating that the RNA was free of
genomic DNA contamination. AKiss1 product was observed when
hypothalamic cDNA was used from wild-type mice as a positive
control.
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FIGURE 2 | Developmental time course of Gpr54 and Kiss1 expression
in the mouse testes. Testes of wild-type (WT), Kiss1+/− and Gpr54+/− mice
at different ages were cryosectioned, stained for β-galactosidase activity,
and counterstained with Saffronin. Blue dots (arrowed) indicate expression
of the Kiss1 and Gpr54 genes. All photographs are at the same
magnification. Scale bar=50µm.
As the MA-10 cells expressed the kisspeptin receptor, they were
tested to see whether Kp10 could stimulate progesterone release.
The cells were divided into two experimental groups. The first
group was treated with increasing concentrations of human Kp10
followed by PBS, and the second group was treated with Kp10
followed by hCG to examine possible synergistic effects. After 4 h,
the media was assayed for progesterone, which was normalized to
the protein content of the cell lysate to correct for variations in
cell number. No significant difference in progesterone release was
found between the vehicle (PBS) treatment and any of the three
concentrations of Kp10 (Figure 3B), indicating that Kp10 cannot
enhance progesterone release from the Leydig cell line even at a
high concentration (20µM). There was also no significant differ-
ence in progesterone release between the cells treated with hCG
FIGURE 3 |The MA-10 Leydig cell line expresses Gpr54 but do not
respond to Kp10 treatment. (A) RT-PCR gene expression analysis in the
MA-10 Leydig cell line. Expression of Gpr54, GnRH, and β-actin was
detected in cDNA from the MA-10 cells but Kiss1 expression was not
detected. Hypothalamic cDNA was included as a positive control for Kiss1
expression. (B) Effect of Kp10 on stimulating progesterone release from the
MA-10 cell line. The MA-10 cells were stimulated with the hormones
indicated and media collected after 4 h and tested for progesterone.
Different letters (a and b) indicate statistically significant differences
between groups (P <0.05, one way ANOVA with a Tukey comparison
post-test).
alone or those treated with hCG and Kp10 (Figure 3B), which sug-
gests that Kp10 has no synergistic effect on progesterone release
from MA-10 cells activated by hCG. However, there was a signifi-
cant difference (P < 0.05) in progesterone release between the cells
treated with PBS and those treated with hCG (Figure 3B), which
indicates the functional responsiveness of the cells to hormonal
stimulation.
Kp10 DOES NOT STIMULATE TESTOSTERONE RELEASE FROM TESTES
TISSUE CULTURE EXPLANTS
To examine the possible action of Kp10 in a more physiologi-
cal system, we tested whether Kp10 could stimulate testosterone
release from primary explants of mouse testes. Pieces of adult wild-
type mouse testes of similar weight (approximately 40 mg/piece)
were treated with vehicle (PBS), Kp10 (1µM), hCG (0.6 IU/ml),
or a mixture of Kp10/hCG. Each condition was repeated with
at least four samples. The media was collected at different time
intervals for testosterone measurements. During the 0- to 4-h
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time period, the testosterone released after hCG treatment was
significantly higher than that with the vehicle (PBS) treatment
(Figure 4A), indicating that the cultured testes maintained the
ability to respond to hormone stimulation. However, there was
no obvious stimulation of testosterone release after Kp10 treat-
ment. Also, the testosterone released in the PBS and hCG groups
was not significantly different at incubation times >4 h due to
increased unstimulated testosterone release (Figure 4A). There-
fore, a 4-h incubation time was used to test whether there was any
synergy between Kp10 and hCG in stimulating testosterone release
(Figure 4B). Once again, testosterone release after hCG treatment
was significantly higher than after PBS treatment (Figure 4B). No
difference in testosterone release was detected between the testes
fragments cultured in PBS or Kp10. There was also no difference
in testosterone release between testes treated with hCG only and
testes treated with hCG and Kp10 together. These data indicate that
Kp10 has no effect on testosterone release from adult mouse testes
and it has no synergistic action on testosterone release stimulated
by hCG.
DISCUSSION
Kisspeptin neuropeptides are important central regulators of the
mammalian reproductive axis with kisspeptin neurons acting
upstream of GnRH neurons to stimulate GnRH release. In addi-
tion to this central role however, the expression profiles of Kiss1
and Gpr54 suggest that they may also have a function in periph-
eral tissues including the testes. We have shown using expression
of a gene targeted LacZ reporter gene, that Kiss1 and Gpr54 are
expressed by round spermatid cells in the mouse testes. Expression
profiling during postnatal gonadal maturation confirmed this as
the expression only started to emerge after 1 month of age, which
is the time when the spermatids first appear. As both Kiss1 and
Gpr54 were found to be expressed in spermatids, this raises the
possibility that autocrine or paracrine kisspeptin signaling might
be involved in spermiogenesis.
Round spermatid cells have just completed meiosis and will
subsequently undergo the structural changes required to produce
spermatozoa. During this structural remodeling, most of the cyto-
plasm is removed from the spermatids by the Sertoli cells, which
will result in loss of β-galactosidase activity, which might explain
why we do not observe staining in elongating spermatids and
spermatozoa. Similarly, this cytoplasmic removal would remove
any kisspeptin protein but GPR54 should be retained by virtue
of its location in the plasma membrane. Indeed, GPR54 has
been detected in the head region of human sperm and addition
of kisspeptin can produce a modest rise in [Ca2+]i and sperm
motility (14).
The functional significance of Kiss1 and Gpr54 expression in
spermatids and sperm is still not clear however. The infertility
of the Kiss1 and Gpr54 mutant mice prevents performing func-
tional tests with mutant sperm. It might be possible to initiate
spermatogenesis in the mutant mice with pulsatile FSH and subcu-
taneous testosterone delivery. Although we have shown that Kiss1
and Gpr54 mutant mice can initiate a low level of spermatogen-
esis when given a chow diet containing phytoestrogens (23), the
number of sperm that can be isolated from the vas deferens and
epididymis is too small for functional studies. It is noteworthy,
FIGURE 4 |Testing Kp10 stimulation of testosterone release from fresh
testes explants. (A)Time course of testosterone release from explanted
mouse testes tissue. Pieces of adult mouse testes were cultured in PBS,
Kp10 (1µM), or hCG (0.6 IU/ml), respectively. The media was collected at
the time points indicated, and testosterone levels measured by an ELISA.
(B) Evaluation of synergistic action of Kp10 on hCG-mediated testosterone
release. Pieces of adult mouse testes were cultured in PBS, Kp10 (1µM),
hCG (0.6 IU/ml), or a mixture of Kp10 (1µM) and hCG (0.6 IU/ml). The media
was collected after 4 h incubation and testosterone levels measured by an
ELISA. n≥4 for all columns. *Statistically significant difference (P <0.05)
between the hCG and the vehicle control group (PBS) (unpaired t -test with
Welch’s correction).
however, that several male patients with mutations in GPR54 and
hypogonadotropic hypogonadism have responded to exogenous
hormone treatment and achieved fertility [for review, see Ref.
(24)] suggesting that in humans, GPR54 function is not essential
for sperm function.
There is an important caveat to this expression data however.
Although the LacZ expression indicates that the Kiss1 promoter is
transcriptionally active in round spermatid cells, we could not
detect kisspeptin immunoreactivity using a validated antibody
capable of visualizing kisspeptin in the hypothalamus of mice (25).
It is possible that the expression level of the kisspeptin protein
is below the limits of detection and that X-gal staining for β-
galactosidase activity is more sensitive. Alternatively, it is possible
that Kiss1 transcripts are not translated into protein in sper-
matid cells. Several gene transcripts encoding proteins required
for late spermiogenesis are expressed in round spermatids and
translationally repressed until the elongating spermatid stage (26).
Translationally repressed mRNAs have unusually long poly(A) tails
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of approximately 180 nt and translation is associated with short-
ening of these tails (27). The presence of long poly(A) tails on
Kiss1 transcripts, which are not subsequently shortened, might
provide a mechanism for the proposed translational repression in
spermatids.
We detected kisspeptin immunoreactivity in Leydig cells of
wild-type mice similar to that reported by Anjum and colleagues
(13). The specificity of this immunoreactivity was suggested by
absence of staining in Kiss1 mutant mice, which do not produce
any kisspeptin protein (5). This notwithstanding, we believe that
the kisspeptin immunoreactivity found in the Leydig cells may not
be authentic for the following reasons. Firstly, we did not detect
Kiss1 promoter activity in Leydig cell by β-galactosidase staining
in Kiss1+/− mice. Secondly, we did not detect Kiss1 transcripts
by RT-PCR in the immortalized Leydig cell line MA-10 although
this may be a consequence of the cell immortalization process
and the tendency for Kiss1 expression to be suppressed during
cell transformation and tumorigenesis. Finally, we failed to detect
kisspeptin immunoreactivity in the Leydig cells of Gpr54 mutant
mice, which can produce kisspeptin protein. We believe that the
staining pattern observed in the Leydig cells of the wild-type
mice is an artifact perhaps associated the high levels of steroido-
genesis in these cells, which does not occur in Kiss1 or Gpr54
mutant mice.
We also observed a very low level of β-galactosidase staining
in Leydig cells from Gpr54+/− mice suggesting that these cells
might express GPR54 protein. This was consistent with our detec-
tion of Gpr54 transcripts in the immortalized mouse Leydig cell
line MA-10. Unfortunately, there are no anti-GPR54 antibodies
with sufficient specificity to confirm expression of the endogenous
GPR54 protein in the Leydig cells.
If there was co-expression of GPR54 and kisspeptin in Ley-
dig cells, this would allow local autocrine or paracrine action
within the testes. Previously published work has suggested that
kisspeptins are able to enhance testosterone release after LH stim-
ulation (17). We therefore examined whether Kp10 was able to
stimulate testosterone release from the MA-10 cell line as well as
testes fragments in culture. We found no evidence that Kp10 could
directly stimulate testosterone release or enhance the actions of
LH. This is in contrast to the recent data that kisspeptin adminis-
tration significantly increased hCG-stimulated testosterone levels
in acyline treated Rhesus monkeys compared to the responses with
hCG treatment alone (17). As the acyline inhibits endogenous
LH secretion from the pituitary, these responses suggest a direct,
synergistic action of kisspeptin on the testes. The reason for the
difference from our data is not known, but apart from a species
difference, it might be that the enhancement by kisspeptin requires
a sub-threshold level of LH stimulation and the concentration of
hCG that we used was too high. It would be informative to test
Kp10 responses to a lower range of hCG treatments in the testes
explants. It is noteworthy, however, that Huma and colleagues have
found that an intravenous injection of the kisspeptin antagonist
p234 does not alter plasma testosterone levels in adult Rhesus
macaques (28) suggesting that any action of kisspeptin on the
testes is small. This conclusion is consistent with the observation
that fertility can be restored in Gpr54 mutant mice by expres-
sion of a Gpr54 transgene in GnRH neurons (29) indicating that
GPR54 expression in the testes is also not essential for fertility
in mice.
In summary, we have shown that the Kiss1 and Gpr54 are
both expressed in round spermatid cells of the mouse testes
and Gpr54 is expressed by Leydig cells but we have not found
any supporting data that kisspeptin signaling in the testes has
a major role in spermatogenesis or testosterone secretion in the
mouse.
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